Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gelbard

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Biorxiv : the Preprint Server for Biology|October 31, 2023
Neutrophilia with damage to the blood-brain barrier and neurovascular unit following acute lung injuryHerman Li, Linh Le, Mariah Marrero, et al.
The New England Journal of Medicine|November 1, 1984
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled studyC L Sprung, P V Caralis, E H Marcial, et al.
The European Journal of Neuroscience|July 5, 2006
Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neuronsZiye Sui, Lynn F Sniderhan, Shongshan Fan, et al.
Brain, Behavior, and Immunity|March 11, 2020
Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosisJennetta W Hammond, Matthew J Bellizzi, Caroline Ware, et al.
AIDS (London, England)|July 25, 2012
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized micePrasanta K Dash, Howard E Gendelman, Upal Roy, et al.
AIDS (London, England)|June 12, 2010
Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youthSuad Kapetanovic, Erin Leister, Sharon Nichols, et al.
Journal of Neurovirology|June 6, 2013
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patientsQing Ma, Harris A Gelbard, Sanjay B Maggirwar, et al.
Journal of Neuroimmunology|June 23, 2009
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disordersDawn Eggert, Prasanta K Dash, Nawal Serradji, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2026
SEZ6L2 Loss Disrupts Motor Coordination, Cognitive Function, and Synaptic ConnectivityJulia M Granato, Nina Silver, Alison Hobbins, et al.
The Journal of Biological Chemistry|July 4, 1998
Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesisS W Perry, J A Hamilton, L W Tjoelker, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|October 31, 2023
Neutrophilia with damage to the blood-brain barrier and neurovascular unit following acute lung injuryHerman Li, Linh Le, Mariah Marrero, et al.
The New England Journal of Medicine|November 1, 1984
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled studyC L Sprung, P V Caralis, E H Marcial, et al.
The European Journal of Neuroscience|July 5, 2006
Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neuronsZiye Sui, Lynn F Sniderhan, Shongshan Fan, et al.
Brain, Behavior, and Immunity|March 11, 2020
Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosisJennetta W Hammond, Matthew J Bellizzi, Caroline Ware, et al.
AIDS (London, England)|July 25, 2012
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized micePrasanta K Dash, Howard E Gendelman, Upal Roy, et al.
AIDS (London, England)|June 12, 2010
Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youthSuad Kapetanovic, Erin Leister, Sharon Nichols, et al.
Journal of Neurovirology|June 6, 2013
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patientsQing Ma, Harris A Gelbard, Sanjay B Maggirwar, et al.
Journal of Neuroimmunology|June 23, 2009
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disordersDawn Eggert, Prasanta K Dash, Nawal Serradji, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2026
SEZ6L2 Loss Disrupts Motor Coordination, Cognitive Function, and Synaptic ConnectivityJulia M Granato, Nina Silver, Alison Hobbins, et al.
The Journal of Biological Chemistry|July 4, 1998
Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesisS W Perry, J A Hamilton, L W Tjoelker, et al.
Pageof 15